All Stories

Moderna targets more cost cuts amid broader vaccine market uncertainty under HHS secretary RFK Jr.

Moderna is extending its cost savings program into 2027 and targeting a cash breakeven point sometime in 2028 as the mRNA biotech faces multiple regulatory uncertainties around vaccines under the Trump administration.

May 1, 2025 - 16:32
 0
Moderna targets more cost cuts amid broader vaccine market uncertainty under HHS secretary RFK Jr.
Moderna is extending its cost savings program into 2027 and targeting a cash breakeven point sometime in 2028 as the mRNA biotech faces multiple regulatory uncertainties around vaccines under the Trump administration.
Read More

Tags:

Previous Article

Don't Let The 'Whispering Death' Nickname Stop You From Riding The Most Dangerou...

Next Article

No ‘bank shots’: Marine Corps chief tells industry to keep pitches focused on Ma...

Related Posts

Delivering Hope: Building a Network to Deliver Radioligand Therapies

Delivering Hope: Building a Network to Deliver Radiolig...

Apr 28, 2025  0

AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer

AstraZeneca, Daiichi say Enhertu delivers 'highly stati...

Apr 21, 2025  0

As vaccine sales slip, GSK touts 'mitigation options' for potential drug tariffs

As vaccine sales slip, GSK touts 'mitigation options' f...

Apr 30, 2025  0